Philips and PathAI team up to improve breast cancer diagnosis using artificial intelligence technology in ‘big data’ pathology research
Royal Philips, a global leader in health technology, and PathAI, a company that develops artificial intelligence technology for pathology, are collaborating with the aim to develop solutions that improve the precision and accuracy of routine diagnosis of cancer and other diseases. The partnership aims to build deep learning applications in computational pathology enabling this form of artificial intelligence to be applied to massive pathology data sets to better inform diagnostic and treatment decisions.
to read the entire article. Please